Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124827502 | 12482750 | 2 | F | 20160715 | 20160620 | 20160725 | EXP | PK-PFIZER INC-2016306380 | PFIZER | 70.00 | YR | F | Y | 0.00000 | 20160725 | MD | PK | PK |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124827502 | 12482750 | 1 | PS | SUTENT | SUNITINIB MALATE | 1 | 25 MG, 1X/DAY | 21938 | 25 | MG | CAPSULE, HARD | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
124827502 | 12482750 | 1 | Metastatic renal cell carcinoma |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
124827502 | 12482750 | DE |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
124827502 | 12482750 | Disease progression | |
124827502 | 12482750 | Metastatic renal cell carcinoma |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
124827502 | 12482750 | 1 | 201510 | 201602 | 0 |